Abstract
FRA3B is the most frequently expressed common fragile site localized within human chromosomal band 3p14.2, which is frequently deleted in many different cancers, including cervical cancer. Previous reports indicate aphidicolin-induced FRA3B instability occurs over ∼500 kb which is spanned by the 1.5 Mb fragile histidine triad (FHIT) gene. Recently an HPV16 cervical tumor integration, 2 Mb centromeric to the published FRA3B region, has been identified. FISH-based analysis with a BAC spanning the integration has demonstrated this integration occurs within the FRA3B region of instability. These data suggest that the unstable FRA3B region is much larger than previously reported. FISH-based analysis of aphidicolin-induced metaphase chromosomes allowed for a complete characterization of instability associated with FRA3B. This analysis indicates that fragility extends for 4 Mb. Within this region are a total of five genes, including FHIT. FRA3B gene expression analysis on a panel of cervical tumor-derived cell lines revealed that three of the five genes within FRA3B were aberrantly regulated. A similar analysis of genes outside of FRA3B indicated that the surrounding genes were not aberrantly expressed. These data provide additional support that regions of instability associated with CFSs and the genes contained within them, may play an important role in cancer development.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- BAC:
-
bacterial artificial chromosome
- CFS:
-
common fragile site
- FISH:
-
fluorescence in situ hybridization
- FS:
-
fragile site
- HPV:
-
human papillomavirus
- Mb:
-
megabase pairs
References
Boldog FL, Gemmill RM, West J, Robinson M, Robinson L, Li E, Roche J, Todd S, Waggoner B, Lundstrom R, Jacobson J, Mullokandov MR, Klinger H, Drabkin HA . 1997 Hum. Mol. Genet. 6: 193–203
Boldog FL, Gemmill RM, Wilke CM, Glover TW, Nilsson AS, Chandrasekharappa SC, Brown RS, Li FP, Drabkin HA . 1993 Proc. Natl. Acad. Sci. USA 90: 8509–8513
Choo KR . 1998 The genetic basis of human cancer Vogelstein B and Kinzler KW (ed) New York: McGraw-Hill, Inc. pp. 631–637
Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS . 1979 N. Engl. J. Med. 301: 592–595
Connolly DC, Greenspan DL, Wu R, Ren X, Dunn RL, Shah KV, Jones RW, Bosch FX, Munoz N, Cho KR . 2000 Clin. Cancer Res. 6: 3505–3510
Cool DE, Fischer EH . 1993 Semin. Cell Biol. 4: 443–453
Coquelle A, Pipiras E, Toledo F, Buttin G, Debatisse M . 1997 Cell 89: 215–225
Corbin S, Neilly ME, Espinosa III R, Davis EM, McKeithan TW, LeBeau MM . 2002 Cancer Res. 62: 3477–3484
Druck T, Berk L, Huebner K . 1998 Oncol. Res. 10: 341–345
Fang JM, Arlt MF, Burgess AC, Dagenais SL, Beer DG, Glover TW . 2001 Genes Chromosomes Cancer 30: 292–298
Gallego MI, Schoenmakers EFPM, Van de Ven WJM, Lazo PA . 1997 Mol. Carcinog. 19: 114–121
Glover TW, Coyle-Morris JF, Li FP, Brown RS, Berger CS, Gemmill RM, Hecht F . 1988 Cancer Genet. Cytogenet. 31: 69–73
Glover TW, Stein CK . 1987 Am. J. Hum. Genet. 41: 882–890
Glover TW, Stein CK . 1988 Hum. Genet. 43: 265–273
Gonzalez MV, Pello MF, Ablanedo P, Suarez C, Alvarez V, Coto E . 1998 J. Clin. Pathol. 51: 520–524
Gostout BS, Podratz KC, McGovern RM, Persing DH . 1998 Am. J. Obstet. Gynecol. 179: 56–61
Greenspan DL, Connolly DC, Wu R, Lei RY, Vogelstein JT, Kim YT, Mok JE, Munoz N, Bosch FX, Shah KV, Cho KR . 1997 Cancer Res. 57: 4692–4698
Hendricks DT, Taylor R, Reed M, Birrer MJ . 1997 Cancer Res. 57: 2112–2115
Herzog C, Crist K, Sabourin C, Kelloff G, Boone C, Stoner G, You M . 2001 Mol. Carcinog. 30: 159–168
Huang H, Qian JH, Proffit J, Wilber K, Jenkins RB, Smith DI . 1998 Oncogene 16: 2311–2319
Huebner K, Garrison PN, Barnes LD, Croce CM . 1998 Ann. Rev. Genet. 32: 7–31
Kang S, Oshshima K, Shimizu M, Amirhaeri S, Wells RD . 1995 J. Biol. Chem. 270: 27014–27021
Kastury K, Ohta M, Lasota J, Moir D, Dorman T, LaForgia S, Druck T, Huebner K . 1996 Genomics 32: 225–235
Krummel KA, Roberts LR, Kawakami M, Glover TW, Smith DI . 2000 Genomics 69: 37–46
Mishmar D, Rahat A, Scherer SW, Nyakatura G, Nihzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, Margalit H, Platzer M, Weiss A, Tsui LC, Rosenthal A, Kerem B . 1998 Proc. Natl. Acad. Sci. USA 95: 8141–8146
Paradee W, Wilke CM, Wang L, Shridhar R, Mullins CM, Hoge AW, Glover TW, Smith DI . 1996 Genomics 35: 87–93
Parniewski P, Bacolla A, Jaworski A, Wells RD . 1999 Nucleic Acids Res. 27: 616–623
Popescu NC, Zimonjic DB, DiPaolo JA . 1990 Hum. Genet. 84: 383–386
Poumay Y, Pittelkow MR . 1995 J. Invest. Dermatol. 104: 271–276
Rabbitts TH . 1994 Nature 372: 143–149
Rassool FV, Le Beau MM, Shen ML, Neilly ME, Espinosa III R, Ong ST, Boldog FL, Drabkin H, McCarroll R, McKeithan TW . 1996 Genomics 35: 109–117
Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R, Le Beau MM . 1991 Proc. Natl. Acad. Sci. USA 88: 6657–6661
Sandberg AA . 1990 The chromosome in human cancer and leukemia 2nd edn New York: Elsevier Science Publishing Co., Inc 1315 pp
Sarkar G, Turner RT, Bolander ME . 1993 PCR Methods Appl. 2: 318–322
Smeets DF, Scheres JM, Hustinx TW . 1986 Hum. Genet. 72: 215–220
Solomon E, Borrow J, Goddard AD . 1991 Science 254: 1153–1160
Tanaka H, Shimada Y, Harada H, Shinoda M, Hatooka S, Imamura M, Ishizaki K . 1998 Cancer Res. 58: 3429–3434
Tatarelli C, Linnenbach A, Mimori K, Croce CM . 2000 Genomics 68: 1–12
Thorland EC, Myers SL, Persing D, Sarkar G, McGovern RM, Gostout BS, Smith DI . 2000 Cancer Res. 60: 5916–5921
Usdin K, Woodford KJ . 1995 Nucleic Acids Res. 23: 4202–4209
Verkerk A, Pieretti M, Sutcliffe JS, Fu YH, Kuhl D, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang F, Eussen BE, van Ommen G-JB, Blonden L, Riggins GJ, Chastain JL, Kunst GH, Caskey CT, Nelson D, Oostra BA, Warren ST . 1991 Cell 65: 905–914
Verma RS, Babu A . 1989 Human Chromosomes: Manual of Basic Techniques Verma RS and Babu A (ed) New York: Pergamon Press, Inc. 240 pp
Vertino PM, Spillare EA, Harris CC, Baylin SB . 1993 Cancer Res. 53: 1684–1689
Walboomers JMM, Jacobs MV, Manos MM, Bosch FX, Kummer A, Shah KV, Sniders PJF, Peto J, Meuer CJLM, Munoz N . 1999 J. Path. 189: 12–19
Wang L, Paradee W, Mullins C, Shridhar R, Rosati R, Wilke CM, Glover TW, Smith DI . 1997 Genomics 41: 485–488
Wilke CM, Hall BK, Hoge AW, Pardee W, Smith DI, Glover TW . 1996 Hum. Mol. Genet. 5: 187–195
Zimonjic DB, Druck T, Ohta M, Kastury K, Croce CM, Popescu NC, Huebner K . 1997 Cancer Res. 57: 1166–1170
Zochbauer-Muller S, Fong KM, Maitra A, Lam S, Geradts J, Ashfaq R, Virmani AK, Milchgrub S, Gazdar AF, Minna JD . 2001 Cancer Res. 61: 3581–3585
Acknowledgements
Supported by NIH Grant CA 48031 and Department of Defense Grant DAMD 17-99-1-9504 to DI Smith.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Becker, N., Thorland, E., Denison, S. et al. Evidence that instability within the FRA3B region extends four megabases. Oncogene 21, 8713–8722 (2002). https://doi.org/10.1038/sj.onc.1205950
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205950
Keywords
This article is cited by
-
Genome-wide high-resolution mapping of mitotic DNA synthesis sites and common fragile sites by direct sequencing
Cell Research (2020)
-
Very large common fragile site genes and their potential role in cancer development
Cellular and Molecular Life Sciences (2014)
-
Molecular characterization of common fragile sites as a strategy to discover cancer susceptibility genes
Cellular and Molecular Life Sciences (2014)
-
Replication dynamics at common fragile site FRA6E
Chromosoma (2010)
-
RORA, a large common fragile site gene, is involved in cellular stress response
Oncogene (2006)